Aimed Bio Inc. (KOSDAQ:0009K0)
South Korea flag South Korea · Delayed Price · Currency is KRW
21,350
-650 (-2.95%)
At close: Oct 22, 2026

Aimed Bio Revenue

Aimed Bio had revenue of 20.20B KRW in the quarter ending June 30, 2026, with 165.61% growth. This brings the company's total for the last twelve months to 66.79B, up 222.57% year-over-year. In the year 2025, Aimed Bio had annual revenue of 47.28B with 302.02% growth. That makes Aimed Bio the 27,988th largest company in the world by revenue and 1,700th in South Korea.

Revenue (ttm)
66.79B
Revenue Growth
+222.57%
P/S Ratio
20.67
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.38T

Revenue Chart

Revenue by Geography

  • Overseas 43.54B 92.1%
  • South Korea 3.74B 7.9%
Fiscal year ended Dec 31, 2025 See the full Aimed Bio breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202547.28B35.52B302.02%
Dec 31, 202411.76B11.59B6,768.70%
Dec 31, 2023171.21M60.12M54.11%
Dec 31, 2022111.09M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.